Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes
Metoprolol is a medication commonly utilized in select patients to achieve a reduction in heart rate, systolic blood pressure, or other indications. A majority of metoprolol metabolism occurs via <i>CYP2D6</i>. Decreased expression of the CYP2D6 enzyme increases the concentration of meto...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/13/3/416 |